Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

PRINCIPLE trial

- PMLiVE

Nearly 16,000 coronavirus cases left out of UK’s daily figures between 25 September and 2 October

PHE chief exec says ‘technical issue’ caused unreported coronavirus cases

- PMLiVE

Moderna CEO says COVID-19 vaccine will be ready for FDA submission in late November

Company will seek emergency use authorisation for experimental vaccine

- PMLiVE

CEPI establishes global network to compare COVID-19 vaccines

Network will include the UK, Canada, the Netherlands, Italy, Bangladesh and India

- PMLiVE

EMA begins rolling review of AZ’s COVID-19 vaccine candidate

Agency has started evaluating data from non-clinical laboratory studies

AstraZeneca AZ

Japan resumes AZ’s COVID-19 vaccine trial, but US study remains on hold

Trials have also resumed in the UK, India, South Africa and Brazil

Fishawack Health, a new breed of global commercialization partner, fit for a post pandemic world

Our parent company, Fishawack Health has reorganized to deliver agile and innovative solutions for life-sciences companies in the face of rapidly changing markets

Blue Latitude Health

Webcast

Monitoring the impact of COVID-19 on the market access landscape

Research Partnership

Covid-19 redefines rules of customer engagement

Oli Hudson, Content Director at Wilmington Healthcare, explores how the pandemic has changed pharma’s relationship with HCPs

Wilmington Healthcare

- PMLiVE

Regeneron’s COVID-19 antibody cocktail reduces viral load and alleviates symptoms

Investigational treatment also helped patients recover faster

- PMLiVE

GSK chief exec ‘optimistic’ COVID-19 vaccine could be available next year

GSK is currently partnering with Sanofi on a COVID-19 vaccine project

- PMLiVE

Moderna’s COVID-19 vaccine generates strong immune response in older adults

New data builds on initial data read-out announced in August

- PMLiVE

Inovio hit with FDA hold on COVID-19 vaccine trial

Trial placed on hold after FDA raises questions over delivery device

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links